COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION

Rhea-AI Summary

CollPlant Biotechnologies (Nasdaq: CLGN), a leader in regenerative and aesthetics medicine, has announced its upcoming financial report and conference call for the second quarter of 2024. The company, known for its innovative non-animal-derived collagen technologies, will release its financial statements on Tuesday, August 20, 2024, before U.S. markets open.

A conference call and webcast are scheduled for 10:00 a.m. EDT on the same day. Investors can participate using various dial-in numbers based on their location. A live webcast will also be available in listen-only mode. To streamline the process, CollPlant offers a Call me™ feature for easy access. Investors can submit questions in advance by emailing Dan Ferry at LifeSci Advisors

News Market Reaction

-4.15%

1 alert

-4.15% News Effect

On the day this news was published, CLGN declined 4.15%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Conference call to be held on Tuesday, August 20, 2024, at 10:00 a.m. U.S. EDT

REHOVOT, Israel, Aug. 6, 2024 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced that it will report financial statements for the second quarter of 2024 on Tuesday, August 20, 2024, before the opening of the U.S. financial markets. The Company will then host a conference call and webcast to discuss its financial statements and corporate updates on August 20 at 10:00 a.m. Eastern Daylight Time.

 

 

Conference call information

To participate in the conference call, please use the dial-in information below:

U.S. investors: 1-877-407-9716 
Investors outside of the U.S.: 1-201-493-6779 
Israel investors: 1-809-406-247
Conference ID: 13746304

Note, you can avoid long wait times for the operator by using the Call me™ feature and clicking the link below 15 minutes prior to the scheduled call start time:
https://callme.viavid.com/viavid/?callme=true&passcode=13728588&h=true&info=company-email&r=true&B=6

Webcast information

A live webcast will also be available in listen-only mode and can be accessed here or via the link to be posted on the News & Events section of the CollPlant Investor relations website. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company's website for a limited time.

Submit questions to management in advance of the call

To ask management a question ahead of the call, please email Dan Ferry at LifeSci Advisors LLC up until 24 hours before the event at daniel@lifesciadvisors.com.

About CollPlant

CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, and are ushering in a new era in regenerative and aesthetic medicine.

In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.

For more information about CollPlant, visit http://www.collplant.com.

Logo: https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg

Contacts:

CollPlant:
Eran Rotem
Deputy CEO & CFO
+972-73-2325600 
eran@collplant.com

Investors:
LifeSci Advisors
Dan Ferry
daniel@lifesciadvisors.com

View original content:https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-date-for-2024-second-quarter-financial-statements-and-conference-call-information-302215375.html

SOURCE CollPlant

FAQ

When will CollPlant Biotechnologies (CLGN) release its Q2 2024 financial results?

CollPlant Biotechnologies (CLGN) will release its Q2 2024 financial results on Tuesday, August 20, 2024, before the opening of U.S. financial markets.

What time is CollPlant's Q2 2024 earnings conference call scheduled for?

CollPlant's Q2 2024 earnings conference call is scheduled for Tuesday, August 20, 2024, at 10:00 a.m. Eastern Daylight Time (EDT).

How can investors participate in CollPlant's Q2 2024 earnings call?

Investors can participate in CollPlant's Q2 2024 earnings call by dialing in using specific numbers for U.S., international, and Israeli investors, or by using the Call me™ feature available 15 minutes before the call.

Will there be a webcast for CollPlant's Q2 2024 earnings call?

Yes, a live webcast of CollPlant's Q2 2024 earnings call will be available in listen-only mode, accessible through a link on the company's Investor Relations website.

How can investors submit questions for CollPlant's Q2 2024 earnings call?

Investors can submit questions for CollPlant's Q2 2024 earnings call in advance by emailing Dan Ferry at LifeSci Advisors up to 24 hours before the event.